HighTower Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,185
| Closed | -$295K | – | 2937 |
|
|
2021
Q1 | $295K | Buy |
3,185
+73
| +2% | +$6.76K | ﹤0.01% | 2308 |
|
|
2020
Q4 | $280K | Buy |
3,112
+431
| +16% | +$38.8K | ﹤0.01% | 1956 |
|
|
2020
Q3 | $278K | Sell |
2,681
-2,769
| -51% | -$287K | ﹤0.01% | 1852 |
|
|
2020
Q2 | $430K | Buy |
5,450
+11
| +0.2% | +$868 | ﹤0.01% | 1527 |
|
|
2020
Q1 | $314K | Buy |
5,439
+586
| +12% | +$33.8K | ﹤0.01% | 1520 |
|
|
2019
Q4 | $262K | Buy |
4,853
+1,018
| +27% | +$55K | ﹤0.01% | 1790 |
|
|
2019
Q3 | $201K | Buy |
+3,835
| New | +$201K | ﹤0.01% | 2047 |
|
|
2018
Q4 | – | Sell |
-5,344
| Closed | -$359K | – | 2114 |
|
|
2018
Q3 | $359K | Buy |
+5,344
| New | +$359K | ﹤0.01% | 1634 |
|